Jenburkt Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 345.66 million compared to INR 330.02 million a year ago. Revenue was INR 360.3 million compared to INR 342.87 million a year ago. Net income was INR 54.34 million compared to INR 62.27 million a year ago. Basic earnings per share from continuing operations was INR 11.84 compared to INR 13.57 a year ago.
For the nine months, sales was INR 1,015.5 million compared to INR 956.9 million a year ago. Revenue was INR 1,054.18 million compared to INR 993.61 million a year ago. Net income was INR 182.53 million compared to INR 188.48 million a year ago. Basic earnings per share from continuing operations was INR 39.77 compared to INR 41.07 a year ago.